MMWR. Morbidity and mortality weekly report · 2014
Global invasive bacterial vaccine-preventable diseases surveillance--2008-2014.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Murray Jillian, Agócs Mary, Serhan Fatima, Singh Simarjit, Deloria-Knoll Maria, O'Brien Katherine, Mwenda Jason M, Mihigo Richard, Oliveira Lucia, Teleb Nadia, Ahmed Hinda, Wasley Annemarie, Videbaek Dovile, Wijesinghe Pushpa, Thapa Arun Bhadra, Fox Kimberly, Paladin Fem Julia, Hajjeh Rana, Schwartz Stephanie, Van Beneden Chris, Hyde Terri, Broome Claire, Cherian Thomas, Centers for Disease Control and Prevention (CDC)
Аннотация
Meningitis and pneumonia are leading causes of morbidity and mortality in children globally infected with Streptococcus pneumoniae (pneumococcus), Neisseria meningitidis, and Haemophilus influenzae causing a large proportion of disease. Vaccines are available to prevent many of the common types of these infections. S. pneumoniae was estimated to have caused 11% of deaths in children aged <5 years globally in the pre-pneumococcal conjugate vaccine (PCV) era. Since 2007, the World Health Organization (WHO) has recommended inclusion of PCV in childhood immunization programs worldwide, especially in countries with high child mortality. As of November 26, 2014, a total of 112 (58%) of all 194 WHO member states and 44 (58%) of the 76 member states ever eligible for support from Gavi, the Vaccine Alliance (Gavi), have introduced PCV. Invasive pneumococcal disease (IPD) surveillance that includes data on serotypes, along with meningitis and pneumonia syndromic surveillance, provides important data to guide decisions to introduce PCV and monitor its impact.